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1. Introduction  
Human beings consume protein-rich foods to supply their nutritional requirements, mainly 
of animal origin, such origin lying in meat from different species (cattle, sheep, caprines, 
birds, pigs, fish and seafood/shellfish), milk and eggs. With the exception of some products 
derived from fishing, these foods are obtained from financial exploitations in which the 
animals’ health must be guaranteed, thereby ensuring that food is harmless. In several 
countries the safety of such food has mainly been focused on avoiding the transmission of 
zoonotic diseases, less attention thus being paid to potentially present chemical residues, 
perhaps due to the course of the resulting disease. Whilst infectious processes are frequently 
of the acute type, toxicosis caused by contaminants in foods (more than acute) may be 
chronic, silent and often lacking a known aetiological agent.  
The primary production of such food involves the animals’ interaction with their setting 
from which they may become exposed to undesirable chemical substances which may 
generate residuality. The chemical substances to which animals may become exposed 
during their production cycle which have been identified to date could come from drugs 
and growth promoters aimed at treating diseases and improving production parameters, 
biologically-derived toxins (mycotoxins, phycotoxins, phytotoxins) and/or environmental 
contaminants linked to atmospheric pollution, from the soil and/or water. This chapter will 
be orientated towards dealing with residues from chemicals substances in foodstuffs of 
animal origin caused by drugs and growth promoters, as well as by toxins having a 
biological origin. It will also deal with general concepts such as toxic agent’s target in an 
organism, the regulation of residues in food and the analytical methods used for detecting 
them. The contamination of food by chemical risks is a worldwide public health matter 
which may also hamper international trade.  
2. The destination for toxic agents in an organism 
Living beings continuously are being exposed to external substances, generically called 
xenobiotics, which can have adverse effects according to their chemical characteristics. Oral, 
dermal and inhalation routes represent the commonest means of exposure to these 
substances, the first being of interest as it deals with risks to human health due to the 
consumption of foodstuffs contaminated by potentially toxic substances. On the other hand, 
animals (representing a readily available source of food for humans) are exposed to 
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xenobiotics in multiple ways which could be present in their products. If one is dealing with 
veterinary drugs then the route of exposure could be oral (for example, coccidiostatics in 
poultry), dermal (e.g. external antiparasitic agents in ruminants), parenteral (e.g. antibiotic 
treatment in large animals) and even inhalation (if the animals are given anaesthesia before 
surgical procedures). Biologically-derived toxins mainly enter food-producing animals by 
the oral route (e.g. forage contaminated with mycotoxins or fish consuming toxic algae). 
Xenobiotics in an organism go through a series of stages including absorption, distribution, 
metabolism and excretion, forming part of the pharmacokinetics or toxicokinetics according 
to the effects produced by a particular substance (pharmacological or toxicological). 
Xenobiotics enter a food-producing animals’ organism and, according to its kinetics, reach 
the tissues which will become food for human beings (Figure 1). These concepts will be dealt 
with below, approaching them from the perspective of potential residuality which different 
substances can cause in an animal’s organism. 
 
Fig. 1. Destination of toxicants in foodstuffs animal organism and risk for humans 
www.intechopen.com
 
Chemical Residues in Animal Food Products: An Issue of Public Health 165 
2.1 Absorption 
During absorption, the xenobiotics cross cell membranes and reach the systemic circulation. 
Many toxic agents enter with foodstuff and are absorbed by the same routes as the other 
substances present in them. The chemicals cross the cell membrane’s lipid bilayer through 
two basic processes: diffusion (favouring their concentration gradients) and active transport 
(against their concentration gradients). Most liposoluble xenobiotics are transported by 
simple diffusion through the cell membranes. Organic acids and/or bases thus tend to 
become absorbed when they are in their most liposoluble form (non-ionised), which is 
determined by surrounding pH. Weak acids will become more easily absorbed in the 
stomach whilst this will happen to bases in the intestines. Hydrophilic substances having a 
small molecular weight become diffused through aqueous pores formed by proteins 
(facilitated diffusion). Active transport, against concentration gradients requiring an 
expenditure of energy, occurs through proteins present on the membrane mobilising a 
substance from one side to another (Lehman-McKeeman, 2008). 
It should be born in mind that certain factors may sometimes alter xenobiotics’ absorption; 
for example, the flora present in the gastrointestinal tract may transform them and leave 
them less available for being absorbed. This is why ruminants are resistant to some 
mycotoxins. Pre-systemic elimination of a toxic agent may occur with enterohepatic 
circulation, thereby minimising its potential adverse effect. 
2.2 Distribution 
Once it has been absorbed, a toxic agent becomes distributed throughout the whole body; 
during its initial phase this distribution is dominated by the blood flow. The penetration of 
toxic agent into the cells depends on passive diffusion or specialised transport; however, 
certain toxicants do not cross the membranes and become distributed via the blood flow. 
Some become accumulated in determined parts of the organism as a result of their binding 
to proteins or their high solubility in fat. When a toxicant becomes stored, then equilibrium 
is reached with the free fraction which is in the plasma. Thus, when the chemical becomes 
metabolised or is excreted, then substance is released from the storage site, thereby meaning 
that the xenobiotic half-life could become very long.  
Albumin is the main plasmatic protein transporting xenobiotics. This protein may also be a 
toxicant reservoir since it impedes transport through the membranes due to its high 
molecular weight. The presence of toxic agents in the blood could be exploited for 
recognising exposure, whether in humans or animals. 
Many organic compounds are very stable and lipophilic, becoming accumulated in the 
environment, becoming rapidly absorbed and concentrated in body fat. The toxicants 
become accumulated in fat because they are dissolved in it. A substance stored in fat is not 
toxic for the carrier, but there is rapid lipid mobilisation, for example poisoning may occur 
during long periods of fasting. Animal fat, a potential reserve of liposoluble toxicants, could 
be consumed by human beings.  
The liver and the kidneys have a large capacity for proteins to bind a broad range of 
chemicals. These organs important function lying in the metabolism and elimination of 
xenobiotics makes them concentrate more toxic agents than all the rest combined. Thus 
consuming such viscera may represent a risk for the end consumer. There is a lower 
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presence of residues in animals’ musculature (meat) compared to the viscera (kidneys, liver) 
and fat. Their accumulation at an injection site is feasible in cases where there has been 
exposure to the intramuscular drug route, this being important in animals which are to be 
consumed by humans.  
The distribution of some chemicals in eggs, as well as reducing palatability, could represent 
a risk for the end consumer. 
2.3 Metabolism  
The object of xenobiotics’ metabolism is to increase characteristics regarding an increase in 
substances’ hydrosolubility so that they can be more easily excreted. This process occurs in 
two phases; hydrolysis, reduction and oxidation reactions are presented during phase 1, 
most of them being enzyme-mediated. Cytochrome P450 (CYP450) oxidation enzymes being 
of particular importance during this phase due to their catalytic versatility and the great 
number of xenobiotics constituted in their substrate. Conjugation reactions occur during 
phase 2, mainly with glucuronic acid, glutathione conjugates and sulphates; such reactions 
are enzymatically mediated by protein superfamilies called, respectively, uridine 
diphosphate glucuronosyltransferase, glutathione S-transferases and sulphotransferases. In 
spite of the initial purpose of xenobiotics’ metabolism (or biotransformation) being 
detoxification, substances can occasionally acquire their true toxic power on being 
biotransformed; such reaction is called bioactivation or metabolic activation. Aflatoxins and 
pyrrolizidine alkaloids are bioactivated substances of interest regarding the residuality 
which they represent in food of animal origin.  
2.4 Excretion 
Toxicants are eliminated from the body by various routes, the kidneys being the most 
important organ for excreting xenobiotics since it is the main elimination route. The biliary 
route involving the faeces is the other elimination route for toxic substances which have 
been consumed. 
Milk is an important elimination route due to the risk of contamination which it represents; 
this liquid is a lipid emulsion in an aqueous protein solution and may thus contain whatever 
toxicant which is in solution in an animal’s body water. Simple chemicals arrive at the 
mammary glands by diffusion in their free form, bound to proteins or dissolved in lipids. 
The percentage of the total amount of compounds eliminated in milk is very low because 
the other elimination routes are more efficient. However, the main problem lies in chronic 
exposure and/or liposoluble compounds (Panter & James, 1990). 
The concept of withdrawal time has been established to avoid the accumulation of drug 
residues in animals; it is defined as being the time required after a drug has been 
administered to an animal to ensure that drug residues in marketable products (meat, eggs, 
viscera or other edible products) are below a determined maximum residue limit (MRL).  
3. Regulating and evaluating risk  
There can never be an absolute guarantee that our food is safe; it is simply impossible to test 
every contaminant. Every country has an agency which oversees food safety; this is defined 
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as being the, “reasonable certainty of no harm,” and the aforementioned agencies regulate 
which additives are allowed in food and what levels of unavoidable contaminants are 
acceptable. The US Department of Agriculture’s (USDA) Food Safety Inspection Service 
(FSIS) is responsible for the safety of meat, poultry, and egg products in the USA (Lodovico 
et al., 2008). The European Food Safety Authority (EFSA) is the keystone of the European 
Union’s (EU) risk assessment regarding food and animal feed safety. The Codex 
Alimentarius Commission (created by the FAO and WHO) develops food standards, 
guidelines and related texts such as codes of practice under the Joint FAO/WHO Food 
Standards Programme (JECFA). The main purposes of this programme are protecting 
consumers’ health, ensuring fair trade practices in the food trade and promoting the 
coordination of all food standards’ work undertaken by international governmental and 
non-governmental organisations. 
Health authorities recommend maximum acceptable or tolerable levels for chemicals which 
are neither genotoxic nor carcinogenic, such as acceptable daily intake (ADI), reference dose 
(RfD), especially for pesticides, tolerable daily intake (TDI) and provisional tolerable weekly 
intake (PTWI) for contaminants which may accumulate in the body. The responsible 
agencies conduct risk assessment to determine such levels; this consists of hazard 
identification and characterisation, exposure assessment and subsequent risk 
characterisation. 
Hazards are identified and characterised from human epidemiological observations and 
animal-based toxicity testing supported by in vitro mechanistic studies which can make 
extrapolation from animals to humans become more realistic. Structure–activity 
relationships-based indications and the increased use of novel molecular biology techniques 
are also very valuable.  
Dose–response information is essential for quantifying an adverse health effect. This may be 
graphically presented as being the relationship between the increase of a dose and the 
increase of a pertinent biological response. Such dose–response curve is essential for 
identifying a non-active dose taken as being the no observed adverse effect level (NOAEL), 
the highest dose of a substance which causes no detectable adverse alteration in line with 
defined treatment conditions. Interspecies differences should be taken into account as well 
as the fact that humans may exhibit substantial differences in their sensitivity to certain 
toxins due to differences regarding metabolic pathways and other factors. Uncertainty 
factors are thus applied when extrapolating from the toxicity observed in laboratory animals 
to health risks in humans, this usually being a factor of 10 for interspecies difference and a 
factor of up to 10 for human variability (depending on the extent and quality of available 
human data).  
The resulting value (equation 1) provides an estimate of the amount of a substance in 
food, expressed on a body weight basis, that can be ingested daily over a lifetime without 
appreciable risk (standard human= 60 kg). The ADI is then used for determining the 
maximum allowable levels of a particular chemical in a specific food, depending on the 
extent to which this food contributes towards the overall intake of such chemical 
(Lodovico et al., 2008). These are called maximum limits for some chemicals and 
maximum residue limits (MRLs) for substances such as veterinary drugs and hormone 
residues.  
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Equation 1. Acceptable daily intake calculation  
The regulatory approach (not strictly scientific) for genotoxic and carcinogenic compounds 
is based on the assumption that there is no threshold dose (it is assumed that one genotoxic 
molecule is sufficient to hit a single DNA base, thereby inducing damage). The aim in this 
case is to keep the exposure level as low as technologically achievable (Lodovico et al., 2008). 
4. Analytical methodologies 
Analytical data quality is a key factor in the success of a control programme dealing with 
residues in foodstuffs. The analytical results of methods regarding official standards offer 
the necessary information for developing and managing programmes responding to a 
population’s public health needs. It is very important that sanitary authorities have readily 
available practical analysis methods which will reliably detect and quantify (without 
ambiguity) a drug’s residues which could be present in meat, milk, or eggs at a suitable 
concentration level. Unfortunately, methods having these attributes are not available for all 
residues, partly due to the large amount of possible substances which may be found in 
animals’ food chains.  
Chemical residues in food of animal origin, such as meat, milk or eggs, are frequently 
present in very low concentrations or trace levels, thereby representing an important 
challenge for a chemical analyst, given that the analytical methods developed must be 
highly sensitive and selective. 
The prior treatment which a sample has received is very important for ensuring that methods 
reach desired detection levels as well as an acceptable level of exactitude and precision, 
thereby enabling the factors responsible for analyte loss to be controlled during such 
procedure (The Spanish Industrial Pharmaceutics Association – Asociación Española de 
Farmacéuticos de la Industria [AEFI], 2001); this would include  the presence of functional 
reactive  groups which can interfere with such determination (LoBrutto & Patel, 2007).  
Analytical methods will always have to be tested/proved on material from each animal 
species since differences in composition (fat, specifics proteins, eg: myoglobin) can influence 
both analyte extraction and separation. Another important consideration concerns the 
treatment which biotransformation enzyme-rich tissues such as the liver should receive as 
this may induce post-mortem metabolism thereby altering real results. Special management 
musts also be used for determining analytes in eggs because eggs consist of two 
distinct compartments (the white and the yolk) whose chemical composition is different, as 
well as depending on the components of chicken’s diet.  
ADI = 
NOAEL 
UF 
ADI   : Acceptable Daily Intake
NOAEL  : Not Observed Adverse Effect Level 
UF         : Uncertainty Factor (10, 100, n) 
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The scientific community focuses on developing reliable, economic and rapid methods (and 
whenever possible automated) which could be applied to evaluating the safety of foodstuffs 
bearing in mind the broad range of existing chemicals and matrices (Botsoglou & Fletouris, 
2000). A unified procedure would eliminate the need for using separate methods for 
detecting multiple residues in the same product; however, such methods are rarely found in 
real life. There is an immense variety of methods for identifying, confirming and 
quantifying analytes which could be used individually or coupled to each other in a suitable 
way. These methods can be grouped into bioassays, microbiology assays, immunochemical 
assays and physical-chemical assays. 
4.1 Bioassays 
Biological methods for determining toxic residues in foodstuffs can be used both in vivo and 
in vitro (FAO, 2004) and have been particularly developed for detecting and quantifying the 
phycotoxins present in shellfish. The mouse bioassay is the most used one and is even 
accepted by regulating entities.  
A toxin extract is intraperitoneally injected into mice having around 20 g body weight in the 
mouse bioassay and their survival is monitored from 24 to 48 hours. One mouse unit (MU) 
is defined as being the minimum quantity of toxin needed to kill a mouse within 24 hours. 
Sample toxicity (MU/g whole tissue) is determined from the smallest dose at which two 
mice or more in a group of three die within 24 hours. The regulatory level is set at 0.05 
MU/g whole tissues in many countries; this assay’s major disadvantages are therefore a lack 
of specificity (no differentiation between various toxin components), subjectivity regarding 
the animals’ time of death as well as maintaining and killing laboratory animals. This assay 
may also give false positives because of interference which can be very toxic for mice. The 
EU has issued directions on how to perform this assay in an attempt to standardise the 
mouse bioassay methodology.  
Other bioassays which are also used would include the suckling mouse assay for detecting 
marine toxins which determin the weight of the intestine regarding body weight, the rat 
bioassay which is based on inducing diarrhoea in rats, the Daphnia magna assay which is 
used for detecting okadaic acid, the intestinal loop assay which determines the 
accumulation of fluids in rabbit intestine and mice and cytotoxicity assays which are based 
on observing morphological changes in cells. 
4.2 Microbiological assays 
The microbiological methods used for detecting antimicrobial residues in foodstuffs are 
based on inhibiting microbial growth, microbial receptor activity and enzymatic reactions 
and could be applied to all types of matrices, usually milk, meat, eggs and honey. Microbial 
inhibition assays involve culturing a microorganism from a standard strain, usually Bacillus 
stearothermophilus, Bacillus subtilis, Bacillus cereus, Micrococcus luteus, Escherichia coli, Bacillus 
megatherium, Sarcina lutea and/or Streptococcus thermophilus (AEFI, 2001). 
4.3 Immunochemical assays  
Immunochemical methods represent an important tool for determining drug residues, given 
their high specificity, they lead to analytes being determined in samples having had very 
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reduced prior cleaning treatment. These assays are based on the reaction of an antigen 
binding to a specific primary antibody or for each antigen, analogously to an enzyme-
substrate reaction. The most common immunochemical methods would include the 
enzyme-linked immunosorbent assay (ELISA), direct and indirect competitive enzyme-
linked immunosorbent assays, immunoaffinity chromatography (IAC), radioimmunoassay 
(RIA), the enzyme-monitored immunotest (EMIT), the fluorescent immunoassay (FIA) and 
the chemiluminescence immunoassay. 
4.4 Physical-chemical assays 
Physical-chemical methods are mainly used for isolating, separating, quantifying and 
confirming the presence of dangerous residues in samples; this requires that the sensitivity 
of a particular selection method and the determinative or confirmation method are similar. 
Numerous procedures based on the analytes’different physicochemical properties have 
been developed for achieving this objective. Even though a drug’s chemical structure greatly 
determines the most suitable method for its determination, different methods are usually 
available for the same analyte due to the large amount of possibilities and by coupling 
different methods to obtain optimum analyte separation and detection.  
Separation methods are based on the principles of chromatography and are generally 
coupled to high sensitivity and selectivity detection techniques leading to quantifying an 
analyte with a high level of precision and exactitude and also its unequivocal identification 
at very low concentration levels. The chromatographic methods used for determining 
analytes in complex matrices would be gas chromatography (GC), high performance liquid 
chromatography (HPLC), ionic chromatography (IC), size exclusion chromatography (SEC), 
supercritical fluid chromatography (SFC), affinity chromatography (AC). 
Spectrometric methods are also used either alone or coupled to chromatographic or 
immunochemical methods such as ultraviolet-visible absorption spectrometry, absorption 
spectrometry in the near and middle infrared sections, fluorescence and chemiluminescence 
spectrometry, X-ray fluorescence spectrometry, atomic absorption spectrometry, atomic 
emission spectrometry (AES), inductively-coupled plasma atomic emission spectrometry 
(ICP-AES), nuclear magnetic resonance (NMR), mass spectrometry (MS) and mass 
spectrometry in tandem (MS/MS) (Mastovska, 2011).  
Other separations methods are used in determined analysis such as capillary electrophoresis 
(CE), electro capillary chromatography (ECC) and polarimetry (Rouessac & Rouessac, 2003). 
5. Veterinary drugs and growth promoters in food of animal origin 
Currently, rearing animals aimed at feeding the human population mainly depends on 
using pharmacologically-active compounds. Using drugs in the animals is fundamental for 
animal health and wellbeing and for the economy of agribusiness. The reported benefits are 
mainly derived from keeping animals in good health, thereby reducing the possibility of a 
disease becoming transmitted from animals to humans. However, residues from drugs used 
in producing food of animal origin could increase the risk of disease in the people who 
consume products from treated animals. 
In principle, all pharmaceutical preparations administered to animals producing foodstuffs 
can give rise to residues in edible tissue, milk or eggs. In addition to drug dose, residue 
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levels depend on withdrawal time. In spite of most drugs representing a relatively low risk 
for the general public, when used responsibly and in line with instructions approved by the 
laboratories making veterinary drugs, adverse reactions have been frequently reported for 
some compounds; these would include antibacterial, antihelminthic, anticoccidial and 
antiprotozoal drugs and growth promoters.  
5.1 Antibacterial drugs 
Residues from antibacterial drugs in food products of animal origin can represent a danger 
for consumers. The poisonous effects are not very probable since the residues are present in 
very low concentrations. Some substances must receive particular attention due allergic 
reactions. The main hazardous effect is likely to be the development of resistant bacterial 
strains following sub-therapeutic doses of antimicrobials being ingested; such resistance 
could be transferred to other bacteria. This could include resistance being transferred from 
non-pathogenic organisms to pathogenic ones which would then no longer respond to 
standard drug treatment (the Institute of Food Technologists [IFT], 2006). However, the 
generally used antibacterial drugs are presented in Table 1. 
Differences in substitutions in the basic ring structures between the various aminoglycosides 
account for the relatively minor differences in antimicrobial spectra and resistance and 
toxicity patterns. Aminoglycosides given in therapeutic dosages mainly cause ototoxicosis, 
but may also cause nephrotoxicosis, allergy and neuromuscular disturbances. 
Chloramphenicol (an antibacterial belonging to the amphenicol group) has been used in 
treatment and prophylactically in food-producing animals for several years now (i.e. 
poultry, calves, pigs, sheep and fish). Chloramphenicol’s most serious toxic effect is bone 
marrow depression which is generally dose-related and reversible but can sometimes be 
fatal in patients who are probably genetically predisposed. A toxic syndrome has been 
reported in newborn infants receiving large doses of chloramphenicol which is characterised 
by vomiting, hypothermia, cyanosis and circulatory collapse followed by death; this 
syndrome rarely occurs in adults. Chloramphenicol may also cause neuritis, encephalopathy 
with dementia and ototoxicity; its use is restricted in many countries, while it is totally 
banned for use in food-producing animals within the European Union and the USA. 
Chloramphenicol and its metabolites could be genotoxic (Lozano & Arias, 2008). 
Differences in substitutions in the basic ring structures between the various aminoglycosides 
account for the relatively minor differences in antimicrobial spectra and resistance and 
toxicity patterns. Aminoglycosides given in therapeutic dosages mainly cause ototoxicosis, 
but may also cause nephrotoxicosis, allergy and neuromuscular disturbances. 
Chloramphenicol (an antibacterial belonging to the amphenicol group) has been used in 
treatment and prophylactically in food-producing animals for several years now (i.e. 
poultry, calves, pigs, sheep and fish). Chloramphenicol’s most serious toxic effect is bone 
marrow depression which is generally dose-related and reversible but can sometimes be 
fatal in patients who are probably genetically predisposed. A toxic syndrome has been 
reported in newborn infants receiving large doses of chloramphenicol which is characterised 
by vomiting, hypothermia, cyanosis and circulatory collapse followed by death; this 
syndrome rarely occurs in adults. Chloramphenicol may also cause neuritis, encephalopathy 
with dementia and ototoxicity; its use is restricted in many countries, while it is totally 
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banned for use in food-producing animals within the European Union and the USA. 
Chloramphenicol and its metabolites could be genotoxic (Lozano & Arias, 2008). 
 
Antibacterials 
Aminoglicosides Streptomycin, kanamycin, amikacin, neomycin, apramycin 
Amphenicols Chloramphenicol, thiamphenicol, florfenicol 
Beta-lactams Penicilins, cephalosporins 
Macrolides 
Erythromycin, spiramycin, kitasamycin, josamycin, 
desmycosin, mirosamycin, tilmicosin, leucomycin, tylosin  
Nitrofurans Furazolidone, nitrofurazone, furaltadone, nitrofurantoin 
Quinolones 
Ciprofloxacin, danofloxacin, difloxacin, enrofloxacin, 
flumequine, marbofloxacin, norfloxacin, ofloxacin   
Sulphonamides 
Sulfadiazine, sulfadimethoxine, sulfamethazine, 
sulfadoxine, sulfaethoxypyridazine, sulfaguanidine, 
sulfamerazine, sulfamethoxazole, sulfapyridine, 
sulfamethoxydiazine, sulfamethoxypyridazine, 
sulfamonomethoxine, sulfathiazole,  sulfaquinoxaline  
Tetracyclines 
Chlortetracycline, oxytetracycline, demeclocycline, 
doxycycline, methacycline, minocycline 
Antihelmintics 
Benzamidazoles 
Thiabendazol, flubendazol, fenbendazol, mebendazol, 
albendazol,  oxfendazol, febantel 
Imidazotiazoles Levamisole 
Organophosphates Haxolon, coumaphos, dichlorvos 
Tetrahydropyrimidines Morantel, pyrantel 
Salicylanilides Closantel, niclosamide, oxyclozanide, rafoxanide 
Sustituted phenols Dichlorophen, hexachlorophen 
Macrocycliclactones Abamectin, ivermectin, moxidectin 
Piperazinederivates Piperazine, diethylcarbamazine 
Antiprotozoals 
Benzamides Aklomide, nitromide, dinitolmide 
Carbanilides Nicarbazin, imidocarb 
Nitroimidazoles Ronidazole, dimetridazole, metronidazole,  ipronidazole 
Polyether ionophore Monensin, narasin, lasalocid, salinomycin, maduramicin  
Quinolonederivates Buquinolate, decoquinate, methylbenzoquate 
Triazines Clazuril, diclazuril, toltrazuril 
Growth 
promoters 
Antibiotics Monensin, salinomycin, bambermycin, avilamycin 
Anabolic hormones Estradiol-17,  progesterone, testosterone 
Synthetic steroidal 
Boldenone, chlormadinone acetate, ethylenestrol, 
fluoxymesterone, medroxyprogesterone acetate, megestrol 
acetate, methandienone, methylboldenone, 
methyltestosterone, drostanolone, norethandrolone, 
norgestomet, norgestrel, nortestosterone  oxymetholone  
Organic arsenicals Arsanilic acid 
Peptide antibiotics Avoparcin, bacitracin, efrotomycin, enramycin, thiopeptin  
Quinoxaline-1,4-dioxides Carbadox, olaquindox 
Beta-adrenergic agonists 
Bambuterol, bromobuterol, carbuterol, cimaterol, 
clenbuterol, dobutamine, fenoterol, isoproterenol, 
mabuterol, mapenterol, metaproterenol, pirbuterol, 
ractopamine, reproterol, rimiterol, ritodrine, salbutamol  
Table 1. Drugs administrated in treatment and prophylactically in food-producing animals 
Penicillins have low toxicity; hypersensitivity reactions, especially skin rashes, are by far 
their most common adverse effects. Gastrointestinal disturbances including diarrhoea, 
nausea and vomiting may also sometimes appear. No teratogenic effects have been 
reported. Some studies have indicated that sensitive people have experienced allergic 
reactions, such as genera pruritis (itching), difficulty in swallowing and talking, dyspnoea, 
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dermatitis caused by contact and urticaria (hives) caused by consuming residues present in 
meat and/or milk (Medina et al., 2008). The allergic reactions caused by penicillin and its 
derivatives have been considered by the JECFA committee as being determinant factors for 
evaluating and establishing safe residue levels in foodstuffs. The adverse effects associated 
with cephalosporins are similar to those described for penicillins. 
Lincomycine-macrolide is used for the initial treatment of mild to moderate staphylococcal 
infections in calves, sheep, goats and pigs and it is also added in feed for growth-promoting 
purposes. Lincomycine is reported to cause gastrointestinal disturbances including 
diarrhoea, vomiting and nausea which that may prove fatal. Other adverse effects include 
skin rashes, urticaria, polyarthritis, hepatic damage and haematological disturbances (WHO, 
1989). 
All nitrofurans have been widely used in the prophylactic and therapeutic treatment of 
infections caused by bacteria and protozoa in pigs, cattle, poultry, rabbits and fish. The use 
of nitrofurans in food-producing animals has been controversial because residues from 
these drugs may be mutagenic and tumorigenic. Toxicological studies have shown that 
nitrofurazone is a carcinogenic but not genotoxic agent, whereas furazolidone has exhibited 
both carcinogenic and genotoxic properties (WHO, 1993). The metabolites from nitrofurans 
can remain stored for weeks or m animal proteins, including eggs from farmyard birds, 
species in which this compound has been used as an anticoccidial. The systemic use of 
nitrofurans in food producing animals has thus been prohibited in the USA and Europe, 
(EMEA, 1997).  
Quinolones are synthetic antibiotics which are very effective in combating various diseases 
in animal husbandry and aquaculture. The most frequent adverse affects of quinolone 
antibiotics most frequently occurring adverse affects are gastrointestinal disturbances 
including nausea, vomiting, diarrhoea, headache, visual disturbances and insomnia. Rashes, 
pruritus and epidermal necrolysis have sometimes also occurred (Jimenez et al., 2011). 
The residuality of sulphonamides used in treating coccidial and bacterial infections and also 
as growth-promoting agents may cause hypersensitivity reactions, mainly cutaneous rash; 
however, no anaphylactic manifestations caused by this type of residues is known.  
There is sufficient evidence indicating that ingesting the  antibiotics in sub-therapeutic doses 
makes a significant contribution towards the appearance of resistant microorganisms in 
animals which can become transmitted to humans, thereby provoking difficult to treat 
infections. Some sample studies have found antibiotic-resistant coliform microorganisms in 
raw and cooked meat. Likewise, antibiotics consumed by human beings from residues 
present in food of animal origin lead to an alteration of intestinal flora and consequently a 
reduction of bacteria competing with pathogenous microorganisms, thereby increasing the 
risk of disease. 
Tetracyclines can generate bacterial resistance; oxytetracycline particularly induces 
antibiotic resistance in coliform microorganisms present in the human intestine. Recognition 
of this effect has been used by the JECFA committee as the point of reference for defining 
acceptable consumption levels for different antibiotics. 
The problem of resistance is not the only motive for the medical community’s 
preoccupation. Farmers and veterinarians are worried because bacterial resistance in farm 
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animals is interfering with drug efficacy thereby leading to the use of greater 
concentrations than those initially established as being therapeutic. However, in spite of 
antibiotics being the type of veterinary drugs most used in the agribusiness industry, 
there are few options to choose from due to the limited offer of drugs which have been 
approved for use in animals producing foodstuffs compared to those regarding 
therapeutic use in humans. 
5.2 Antihelminthic, anticoccidial and antiprotozoal drugs 
Parasitic diseases constitute an ever present threat in rearing birds and livestock, but they 
may be controlled by adding low levels of drugs to daily rations. The drugs generally 
against internal parasites affecting animals collectively called helminths are shown in Table 
1. Such drugs are used at levels which do not allow resistant strains to develop and also 
become rapidly metabolised in an animal’s organism so that the residues in edible tissues 
are minimal. 
Benzimidazoles, like thiabendazole, are used in sheep, cattle, horses, pigs and poultry. They 
become rapidly eliminated from the organism due to their high solubility; however, some 
studies has shown that these compounds are teratogenic and nephrotoxic in mice and ewes 
(Danaher et al., 2007). Mebendazole metabolits (hydroxylmebendazole and amino-
mebendazole) belonging to the  benzimidazole group and which are widely used as an 
antinematode in horses, sheep, pigs and poultry,  have also been shown to have teratogenic 
effects (Buchmann et al., 1992). 
Levamisol is the most well-known drug from the imidazothiazole group, which has a broad 
spectrum of activity against nematodes; however, it has been found that it induces 
idiosyncratic organulocytosis in some individuals. Levamisol’s toxic effects have caused 
preoccupation in the regulatory bodies and, given that these effects the original compound 
than in its metabolites, this is the analyte of interest in tissue samples. 
Organophosphates represent one of the alternatives for treating benzimidazole-resistant 
nematodes; haloxon (being one of them) is the safest and has been approved by the US Food 
and Drug Administration (FDA) for use in sheep, cattle and goats. By contrast, dichlorvos 
has an acceptable antihelminthic spectrum in cattle and sheep, but it does not have FDA 
approval for use in ruminants due to its suspected carcinogenic effects and narrow safety 
margin (Botsoglou & Fletouris, 2000).  
Ivermectin, a macrocyclic lactone, is exceptionally effective in very low dosages against 
nematodes and arthropod parasites in cattle and has been widely used for treating endo- 
and ecto-parasites in cattle, sheep, goats and pigs; however, ivermectin has had a 
teratogenic effect in rats, rabbits and mice (Moreno et al., 2008). 
Anticoccidial and antiprotozoal drugs are generally used in the poultry industry against 
protozoan infections caused by pathogenic species of Eimeria. Some compounds used as 
antibacterial drugs are also used as coccidiostats, including sulphaquinoxaline, 
sulphadimethoxine, sulphamethoxypyridazine, sulphachlorpyrazine, sulphamethazine, 
sulphaguanidine, furazolidone, nitrofurazone, tetracycline and chlortetracycline. Table 1 
shows compounds whose primary function and use are related to antiprotozoal drugs.  
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A number of nitroimidazoles have already been banned within the European Union, even 
for therapeutic purposes, since they are mutagens and suspected carcinogens. The use of 
ronidazole has been banned by Council Regulation 3426/93/EEC (Official Journal of the 
European Communities, 1993) whereas dimetridazole use is banned by Council Regulation 
1798/95/EEC (Official Journal of the European Communities, 1995). Their antibacterial and 
mutagenic activity is closely related to the reduction of the 5-nitro group, which is common 
to all nitroimidazole drugs. Metronidazole is used for treating bovine trichomoniasis by 
topical application or intravenous injection but it is a genotoxic carcinogen in animals. 
Polyether antibiotics are produced by various actinomyces, mostly Streptomyces species, and 
constitute the agents most widely used by the poultry industry over the last two decades. 
They provide excellent disease control and are refractory for the development of resistance. 
They have a low therapeutic index but may be very toxic in certain species; salinomycin and 
narasin can be fatally toxic in turkeys, for example (Weissinger, 1994). 
The problem of residues from antihelminthic, anticoccidial and antiprotozoal drugs may be 
easily controlled by imposing obligatory withdrawal times, generally 7-10 days, but this is 
unfortunately not always respected. On the other hand, given the large number of drugs 
which may be easily obtained on the market, many producers change one compound for 
another to avoid resistance becoming developed to drugs; however, this increases the 
degree of exposure to thema the misms, which may lead to yet another problem if it is taken 
into account that these drugs are also used as growth promoters. 
5.3 Growth promoters 
Growth promoters are substances which produce improvements in growth rate when added 
to animal feed in sub-therapeutic dosages over an extended period of time. Table 1 shows 
the compounds most commonly used for this purpose. The anabolic hormonal-type growth 
promoters can be classified according to their chemical structure or origin into endogenous 
sex steroids, steroidal compounds, not naturally occurring non-steroidal compounds and 
polypeptide hormones.  
Anabolic hormones (estradiol-17 and progesterone - two female sex hormones, and 
testosterone - one male sex hormone) are used for increasing body mass in livestock rearing. 
Synthetic steroidal compounds have only been approved for therapy regarding 
reproductive behaviour and disorders in non-food-producing animals; however, they are 
used illegally around the world. Boldenone, chlormadinone acetate, ethylenestrol, 
fluoxymesterone, medroxyprogesterone acetate, megestrol acetate, methandienone, 
methylboldenone, methylthisterone, drostanolone, norethandrolone, norgestomet, 
norgestrel, norethisterone (nandrolone), norethisterone decanoate, oxymetholone, and 
stanozolol would be examples of synthetic steroidal compounds which have only been 
approved for therapy regarding reproductive behaviour and disorders in non-food-
producing animals. 
Zeranol and stilbene estrogens, including diethylstilbestrol, hexestrol and dienestrol, are the 
major non-steroidal not naturally occurring compounds included in the class of anabolic 
drugs and somatropin is the most common polypeptide compound affecting growth. 
Diethylstilbestrol, hexestrol and dienestrol are all stilbene estrogens which are currently 
banned worldwide for use in food-producing animals. They are genotoxic, not easily 
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metabolised compounds, which are considered capable of irreversibly initiating the 
carcinogenic process even in small residue concentrations. Diethylstilbestrol and hexestrol 
have been legally permitted for use as anabolics for quite some time in many countries, 
whilst the use of dienestrol, which is a diethylstilbestrol metabolite, has been restricted to 
illegal practice (Dickson, 2003).  
Using these compounds, either natural or synthetic, as growth promoters in meat-producing 
animals has not been allowed in the European Union since 1988, due to potential adverse 
effects to human health, unlike in the United States where some anabolic hormonal-type 
growth promoters are permitted.  
In vivo studies have demonstrated DNA strand breaks and oxidative damage being 
triggered by desencadenados por the 17-┚ estradiol, thereby leading to this hormone being 
considered as triggering a genotoxic effect (for example, the proliferation of carcinogenic 
mammary cells); however, the dosage at which these alterations occur is greater than that at 
which endocrine effects are produced in animals (Mikus et al., 2001). 
Testosterone’s adverse effects are due to its hormonal activity, particularly in the prostate 
gland. Testosterone is also considered to be potentially embryotoxic and its consumption in 
therapeutic doses has led to the induction of hepatic cystitis (Durlinger et al., 2002).  
Following the ban of stilbene and other hormonal-type growth promoters, interest has 
focused on alternative compounds for promoting live weight gain in food-producing 
animals. The beta-adrenergic agonists constitute such group of compounds, clembuterol 
being the main one. It has been reported that consuming calf liver in Spain and France 
containing clenbuterol residues has induced muscular tremors, tachycardia, muscular pain, 
nervousness, headache, vertigo, nausea, vomiting and fever. It has also been used as an 
anabolizant steroid; clenbuterol is used as a tocolytic in cows, thereby supposing an 
additional risk.  
A controversy has arisen around these events regarding whether to accept or prohibit using 
clenbuterol in animal production. This drug increases channel performance, it is not 
potentially oncogenic or mutagenic and is only embryotoxic in large doses whilst its adverse 
effects on consumers becomes evident when recommended withdrawal times are not 
respected and when excessive doses are used, whether through inadequate management or 
aimed at increasing animals’ weight gain even more (Brambilla et al., 2007).  
The foregoing has led to clenbuterol being a highly controlled drug today in many countries 
which have developed programmes and mechanisms for monitoring it and its follow-up. 
However, in spite of these controls and warning signs, unfortunate events involving adverse 
reactions continue to be presented, as happened in November 2005 in Jalisco, México, when 
about 225 people experienced trembling, headaches and discomfort after having consumed 
beef containing residues of this type (Gojmerac, 2002). 
Arsanylic acid, peptide antibiotics and quinoxaline-1,4-dioxides are non-steroidal 
compounds used as growth promoters in different animal species. Arsanylic acid and its 
sodium salt are most commonly used, particularly in pigs. They are also efficacious in the 
egg-producing industry and were previously approved for use in egg-laying hens. 
However, their use in animals is generally rather limited and the risk–benefit ratio is 
questionable because these drugs can produce toxicosis, known as peripheral nerve 
demyelination.  
www.intechopen.com
 
Chemical Residues in Animal Food Products: An Issue of Public Health 177 
In spite of the aforementioned effects, the Codex Alimentarius considers it unnecessary to 
establish an LMR for anabolic hormones as it is improbable that residues arising from the 
correct used of these substances as growth stimulators represent a danger for human 
health. It has also been demonstrated that the endogenous concentration of these 
hormones is greater when they are administered exogenously. Another reason negating 
the potential risk of this type of substance is the availability of metabolic routes which 
become rapidly degraded, meaning that the residues which the meat of treated animals 
may contain do not affect a consumer’s endocrine system. However, dispositions in 
Europe regarding these substances are stricter and do not allow any residual level of 
anabolizant drugs in meats.  
Peptide antibiotics are compounds usually containing D-amino acids. They are usually 
added to animal feeds in low concentrations and produce residues in tissues at very low or 
undetectable levels. Unfortunately, most peptide antibiotics’ metabolic pathways have not 
yet been elucidated. These antibiotics are regulated under separate legislation within the 
European Union (Brogden et al., 2003). 
Quinoxaline-1,4-dioxides and their possible residues in edible animal products have caused 
much debate regarding their mutagenic and carcinogenic potency. Carbadox was initially 
the main drug in use, but suspicion as to its safety arose because this compound exhibited 
both genotoxic and mutagenic activity. Olaquindox is also a strongly mutagenic agent but 
seemingly devoid of carcinogenic activity. 
6. Toxins in food of animal origin 
Toxins have a biological origin, mycotoxins, phycotoxins and phytotoxins having attracted 
most attention due to their potential residuality in foodstuffs, including animal subproducts. 
6.1 Mycotoxins  
Mycotoxins are secondary metabolites from fungi, mainly from the species Aspergillus, 
Fusarium and Penicillium, aflatoxins, ochratoxins, zearalenone, trichothecenes and 
fumonisins having been the most studied to date. The foodstuffs fundamentally 
contaminated by these toxins are grains and cereals constituting the main source of 
contamination for human beings. However, farm animals consuming contaminated 
foodstuffs may generate residues in meat, viscera, milk and eggs. Residuality is determined 
by contamination by high concentrations in foodstuffs ingested by animals, this being very 
uncommon, and also by theway in which the xenobiotic becomes metabolised in the 
organism. Mycotoxins do not become totally destroyed during cooking or industrialisation 
of foodstuffs due to their heat-stability. 
The types of mycotoxicosis (disease resulting from consuming mycotoxins) in human beings 
are mainly chronic. These would include Balkan endemic neuropathy in Russia caused by 
the consumption of ochratoxin A which generates nephrotoxicosis, alimentary toxic aleukia 
in the former Soviet Union associated with dermatitis, vomiting and hematopoietic 
alterations caused by trichothecenes (diacetoxiscirpenol and T-2 toxin), possible endocrinal 
alterations related to reduced masculine fertility caused by consuming zearalenone (such 
toxin acting as an xenoestrogen), hepatic cancer caused by aflatoxin B1 and possible 
esophagic and renal cancer caused by fumonisin and ochratoxin A, respectively. The IARC 
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has classified aflatoxin B1 within group 1 (proven carcinogenic effect on humans) and 
fumonisin B1 and ochratoxin A within group 2B (possibly carcinogenic to humans) (IARC, 
1993). The evidence from in vitro studies has shown that zearalenone is a probably 
implicated in cancer of the reproductive system (Khosrokhavar et al., 2009).  
Aflatoxins and ochratoxin A are the main mycotoxins which can generate residuality and 
attention concerning them as being animal subproduct contaminants has mainly been 
focused on their presence in milk; however, it has been demonstrated that they can also 
generate residuality in meat and eggs.  
6.1.1 Aflatoxins  
Aflatoxins (AF) B1 B2 G1 and G2 are produced by fungi from the genera Aspergillus. AFB1 
may be bioactivated through CYP450 enzymes to become an epoxide which is able to form 
adducts with DNA, meaning that it has been considered that AFB1 undergoes bioactivation 
in the organism. AFB1 may also become hydroxylised to AFM1 and be excreted in milk. It 
has been estimated that  1% to 6% of AFB1 ingested by a milk-producing cow could be 
excreted as AFM1 in milk, depending on bovine productivity. AFM1, like AFB1, may form 
an epoxide and alter DNA sequences. IARC is considered to be an AFM1 in group 2B 
(IARC, 1993). MRL regulated in different countries ranges from 0.05 to 0.5 µg/L; MRL has 
also been established for AF consumed by ruminants (FAO, 2003). Experimental studies 
have shown that when animals consume foodstuffs contaminated by high levels of AF, that 
it is difficult to find naturally, the liver and kidneys are the organs where most toxins 
become accumulated, and their presence in muscle is scarce (Bailly & Guerre, 2009). These 
types of studies have also demonstrated the presence of AF in eggs from different avian 
species.  
6.1.2 Ochratoxin A  
Ochratoxin A (OA) is produced by fungi from the genera Aspergillus and Pencillium,  
the former being from tropical regions and the latter from temperate regions. OA may 
thus be widely distributed throughout the world. OA may become biotransformed 
through hydrolysis reactions in which metabolites become less toxic by the opening of the 
lactone ring which occurs during bioactivation. Detoxification may occur in ruminants 
through digestive flora action before absorption, thereby limiting the possibility that OA 
might be found in milk and/or beef (Bailly & Guerre, 2009). However, a recent study 
evaluating the presence of OA in cows’ milk formulas for infants found contamination in 
72% of the samples analysed, levels around 690 ng/L being found (Meucci et al., 2010). It 
has been shown that OA may become accumulated in pigs’ kidneys. In countries such as 
Denmark, OA levels in these organs are regulated since porcine ochratoxicosis is 
common. 
6.1.3 Fusariotoxins  
The fusariotoxins are mycotoxins which are produced by fungi from the genera Fusarium, 
zearalenone (ZEA), the fumonisins (FUM) and the trichothecenes (TCT) being the most 
important for public health.  
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ZEA is frequently implicated in reproductive disorders in animals and occasionally in 
hyperestrogenism syndromes in humans. ZEA becomes biotransformed in the intestine by 
the mucosa or bacterial flora and involves the formation of ┙- and ┚-zearalenol and ┙- and 
┚-zearalanol. Alpha-zearalanol and ┚-zearalenol have greater estrogenic power than ZEA 
since they bind with greater force to their corresponding receptors (Zinedine et al., 2007).  
Alpha-zearalanol has been employed as growth promoter in cattle. Studies orientated 
towards determining residuality through experimentation have suggested that residues are 
not present in meat or eggs, even at high doses. However, a recent study has show that the 
presence of ┙-zearalenol in meat-based foodstuffs for infants reached levels of 30.5 µg/kg; 
the same study demonstrated the presence of mycoestrogens (ZEA, ┙-zearalenole and ┚-
zearalenole) in infants’ cow milk formulas  (Meucci et al., 2011).  
FUM properties suggest that their presence in animal meat does not represent an important 
source of contamination, since they are poorly absorbed. FUM produce liquefaction of the 
brain in horse and pulmonary oedema in pigs; ruminants and birds are more resistant. They 
have been correlated with oesophageal cancer in humans in some parts of the world and it 
has also been presumed that they may cause neural tube alterations. Their presence has 
been demonstrated and in the liver and kidneys of turkeys fed  with the maximum levels 
permitted in Europe (Tardieu et al., 2008).  
The main TCT of interest in producing animals are T-2 toxin, HT-2 toxin, diacetoxiscirpenol 
and deoxinivalenol. The TCT do not usually represent a risk of contamination in food of 
animal origin due to their rapid metabolism (Bailly & Guerre, 2009).  
6.2 Phycotoxins  
Around 75 species of marine micro-algae, belonging to the dinoflagellate group, produce 
secondary metabolites which represent potent toxins, generically called phycotoxins. These 
organisms form part of the marine plankton and therefore the aquatic food chain leading to 
filtrator mollusks, gastropods, crustaceans and fish which can accumulate toxins being 
consumed (FAO, 2004).  
The microalgae population may increase suddenly and generate an algal bloom which has 
increased in frequency, intensity and geographical distribution during recent years. 
Amongst the explanations put forward to explain for this phenomena has been the 
increased use of coastal waters for aquaculture, eutrophication caused by domestic, 
industrial and agricultural residues, the mobility of trace metals and humic substances due 
to deforestation and/or acid rain and changes in climatic conditions (Erdner et al., 2008). 
Reports of phycotoxins poisoning have increased during the last few years, perhaps due to 
the scientific community’s greater knowledge and interest in the matter or due to the 
increase in algal bloom. Such poisoning is mainly acute course; however, there is interest in 
evaluating the effects being triggered by chronic consumption. The lack of studies on 
animals which are continuously exposed to phycotoxins and the scarce availability of 
certified reference materials have led to difficulties in evaluating risk, developing analytical 
methodologies and regulating these substances.  
Studying toxins produced by algae has classically been approached according to the type 
of poisoning which they have caused. Four groups of toxins can thus be distinguished, 
causing paralytic shellfish poisoning, diarrhoeic shellfish poisoning, amnesic shellfish 
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poisoning and neurotoxic shellfish poisoning (FAO, 2004). Another group of phycotoxins 
of interest due to their accumulation in sea fish are the ciguatoxins causing ciguatera fish 
poisoning.  
6.2.1 Paralytic shellfish poisoning  
The toxins responsible for this poisoning are mainly produced by algae from the genera 
Alexandrium, Gymnodinium and Pyrodinium. Chemically, they correspond to tetrahydropurin 
molecules, saxitoxin (STX) having the most importance. PSP incidence and geographical 
distribution has increased since the 1970s; this poisoning was initially confined to temperate 
waters in Europe, North America and Japan, but is now considered to be worldwide 
problem (FAO, 2004). 
STX becomes rapidly absorbed through the gastrointestinal tract and equally has rapid 
distribution, metabolism and excretion. STX selectively blocks (and with high affinity) 
sodium-dependent channels present in nerves, skeletal muscular fibres and most  cardiac 
muscular fibres, thereby reducing or eliminating the action of propagation potential 
(Etheridge, 2010). 
Paralytic shellfish poisoning symptoms begin in human beings within the first 30 minutes 
following consumption of  contaminated foodstuff and the onset of numbness and/or pins 
and needles around the lips, gradually extending to the face, neck, arms and legs. 
Headaches, nausea, lack of muscular coordination and, occasionally, temporary blindness 
occur. There may be paraesthesia in the arms and legs, motor inability and difficulty in 
talking in moderate cases and paralysis of respiratory muscles leading to death may occur in 
severe cases. 
6.2.2 Diarrhoeic shellfish poisoning  
Diarrhoeic shellfish poisoning toxins are produced by dinoflagellates from the genera 
Dinophysis and Protoceratium, having worldwide distribution. Okadaic acid (OA) and its 
analogues (dinophysis toxins , pectenotoxin  and yessotoxin are included within this 
group. However, yessotoxin and pectenotoxin produce different toxicological effects in 
experimental animals. Yessotoxin is related to lesions in the cardiac muscle, liver, 
pancreas and cerebral neurons and pectenotoxin is clearly hepatotoxic. The effect which 
yessotoxin and pectenotoxin may have on human beings remains unknown (Dominguez 
et al., 2010). 
OA was initially reported in Japan and Europe, areas in which diarrhoeic shellfish poisoning 
has had greater importance. OA and its analogues are potent protein phosphatase inhibitors 
(serine/threonine phosphatases PP1 and PP2A) which dephosphorylate molecules closely 
related to metabolic processes. It has been postulated that OA induces diarrhoea due to an 
alteration in hydric balance in the intestines via one of the two following mechanisms: 
stimulating the phosphorylation of proteins controlling sodium secretion in enterocytes or 
promoting the phosphorylation of intercell binding proteins regulating solute permeability. 
Diarrhoeic shellfish poisoning is characterised by diarrhoea, nausea, vomiting and, in some 
cases,  abdominal pain which can begin within the first 3 or 12 hours after having consumed 
contaminated organisms. No lethal effects have been reported concerning human as having 
been caused by OA or its analogues. 
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6.2.3 Amnesic shellfish poisoning  
This poisoning is also known as domoic acid (DA) poisoning since memory loss is not 
always present. It was described for the first time in Canada (Prince Edward Island) in 1987 
when 105 people became poisoned after consuming blue mussels. There have also been 
several reports of poisoning involving effects on wild life, demonstrating that the toxin 
forms part of the food chain; the toxin responsible for this has been DA which is produced 
by diatoms from the genera Pseudo-nitzschia. 
The DA mechanism of action acts on excitatory amino acid receptors (L-glutamate, L-
aspartate) and/or synaptic transmission. DA activates specific excitatory amino acid L - 
glutamate receptors producing an excessive accumulation of calcium resulting in cell death. 
The kainate receptor is DA’s primary target. Recent interest in DA has been centred on 
recognising that effects can result following chronic exposure to it at low concentrations, 
given the discovery that chemical route alteration leads to neurological disturbances. 
Intestinal absorption is limited (5%-10% of  the dose administered to experimental animals). 
It has high distribution in the blood compartment and scarcely penetrates the 
hematoencephalic barrier. There is no evidence that DA may become metabolised. 
Elimination occurs via the kidneys. Poisoning in humans produces gastroenteritis which 
may be accompanied by headache, confusion and permanent loss of short-term memory 
(FAO, 2004). 
6.2.4 Neurotoxic shellfish poisoning  
Neurotoxic shellfish poisoning, which is endemic on the Gulf of México and the eastern 
coast of Florida, is caused by brevetoxin (BTX) produced by the dinoflagellate Gymnodinium 
breve (synonyms: Ptychodiscus breve, Karenia brevis) present in red-tides. This alga has the 
special feature of being able to form aerosols due to wave action thereby constituting a risk 
of aerial exposure. 
BTX are liposolube toxins consisting of around 14 different substances, leading to 
depolarisation opening sodium channels in cell membranes and increasing the inflow of 
sodium causing persistent and repetitive activation. Symptoms caused by oral exposure to 
BTX occur within the first 30 minutes to 3 hours after consuming contaminated organisms 
and include vomiting, diarrhoea, shivering, sweating, conflicting perception of temperature, 
hypotension, arrhythmias, numbness, paraesthesia of the lips, face and extremities, cramps, 
bronchoconstriction, paralysis, convulsions and coma. There have been no reports of 
lethality. Respiratory difficulty and irritation of the mucosa are the most common symptoms 
when inhalatory exposure occurs. 
6.2.5 Ciguatera fish poisoning  
Ciguatera fish poisoning is caused by ciguatoxin (CTX) which is produced by dinoflagellates 
from the genera Gambierdiscus. CTX becomes accumulated through the food chain, from 
small herbivorous fish up to large carnivorous fish. This poisoning has passed from being a 
problem limited to insular regions which affected local communities to being a global 
matter, given the worldwide consumption of seafood and international tourism. This is the  
most common poisoning caused by seafood and may affect up to 50,000 people annually 
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(FAO, 2004). CTX are liposoluble toxins having 13 to 14 rings fused in a rigid structure. CTX 
bind to sodium channels causing them to open during cell membranes’ potential repose 
altering bioenergetic mechanisms. CTX acts on the same receptor as BTX does but with 
greater affinity (Lehane & Lewis, 2000).  
Gambierdiscus toxicus, the alga specie most commonly related to CTX production, is 
distributed throughout the tropical region of the Pacific Ocean, western Indian Ocean and 
the Caribbean where CFP is endemic. Many coral fish species are involved, including 
herbivores and carnivores. The latter constitute the main vector for poisoning in humans, 
particularly Muraenidae (moray eels), Lutjanidae (snappers), Carrangidae (carrangs), 
Scombridae (mackerels) and Sphyraenidae (barracuda) (FAO, 2004).  
CTX become rapidly absorbed through the intestine and are mainly excreted in the faeces 
via the bile. The symptoms are gastrointestinal or neurological in nature, the former include 
vomiting, diarrhoea, nausea and abdominal pain. The neurological symptoms which can 
begin later include pins and needles in the lips, hand and feet, disturbances in perception of 
temperature, severe pruritus and fatigue. Some patients can experience pain (muscular, 
articular and dental) and anxiety. There may be hypotension and bradycardia in severe 
cases and death may occur, though this is not very common. The neurological symptoms 
can persist for years in some cases; it seems that the toxin may become accumulated in fat 
and be released in certain circumstances or also produce an immunological response 
(Shoemaker et al., 2010). 
Other phycotoxins of interest due to their residuality are the azaspiracida, discovered in 
1998, and whose symptoms resemble those of diarrhoeic shellfish poisoning; the cyclic imins 
(gymnodimine, spirolids, pinnatoxins, prorocentrolide, spirocentrimine and pteriatoxin), 
still have no associated effects in humans, but their residuality does interfere with the 
analytical methodologies used for determining the presence of marine toxins and 
cianotoxins (nodularin and cylindrospermin) by producing hepatoxicity and inhibiting 
protein synthesis.  
6.3 Phytotoxins  
Plants have secondary metabolites with which they defend themselves from the aggression 
of herbivorous animals. Many of these are toxic for humans and animals, causing numerous 
pathologies. Given that the diverse compounds present in plants are degraded during 
digestion and/or the metabolism of xenobiotics in animals of livestock interest, only some 
manage to contaminate products of animal origin. Milk is the main subproduct which has 
been studied in which toxins from plants may be present; however, their presence has also 
been demonstrated in muscle, viscera and eggs. Regulations regarding these toxins are 
scarce and are mainly orientated towards their presence in botanical products having 
pharmacological uses; however, there is growing interest in making advances in this field. 
The regulating entities have shown the greatest interest in pyrrolizidine alkaloids amongst 
the plant toxins due to their abundance and proven toxic effects. 
6.3.1 Pyrrolizidine alkaloids  
Pyrrolizidine alkaloids (AP) are present in a large variety of  plants and are perhaps the 
most widely distributed toxins. Foodstuffs or botanically-based remedies represent the most 
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probable risk of exposure for humans; however, food of animal origin can also contain 
pyrrolizidine alkaloids. It has been presumed that more than 6,000 plant species contain AP, 
mainly those belonging to the families Asteraceae or Compositae (genera Senecio and 
Eupatorium), Boraginaceae (genera Heliotropium and Echium) and Fabaceae or Leguminosae 
(genera Crotalaria).  
APs are heterocyclic compounds which are mainly derived from four necine bases: 
retronecine, heliotridine, otonecine and platynecine. AP can become enzimatically 
hydrolised or oxidised; the resulting N-oxide is slightly toxic and may also be found in 
plants. AP becomes bioactivated to a toxin pyrrole through CYP450 which is electrophilic 
and unstable and reacts rapidly with endogenous macromolecules (particularly with DNA 
forming adducts). DNA adducts could be a continuous source of carbon ions originating 
new adducts, meaning that the total elimination of AP derivates may take months (Edgar et 
al., 2011).  
AP levels in foodstuffs are rarely so significant that they can cause acute diseases; however, 
low levels and continuous exposure could lead to the presentation of chronic diseases which 
could hardly be attributable to the toxin in foodstuffs. Pyrroles cause thickening and 
occlusion of the hepatic vessels resulting in veno-occlusive disease and cirrhosis. They can 
also alter the pulmonary vessels, causing pulmonary hypertension and congestive cardiac 
failure. The IARC has classified lasiocarpine, monocrotaline and riddelliine AP within group 
2B (probably carcinogenic for humans, given the pertinent evidence regarding how they are 
cancerigens in animals) (Edgar et al., 2011).  
It has been demonstrated that 0.1% to 4% of AP in foodstuffs for lactating cows and sheep 
could be excreted in milk (Hoogenboom, 2011). The meat and viscera of cattle fed on AP-
rich plants may contain the toxin and its derivates at levels reaching 250 mg/kg in muscle 
and 2,500 mg/kg in liver (Fletcher et al., 2011). AP can potentially be present in eggs when 
fowl are fed on AP-rich diets, thereby constituting a risk for human health (Eröksüz et al., 
2008). In spite of potential contamination in milk, meat, viscera and eggs, honey is the only 
foodstuff of animal origin which has been shown to be naturally contaminated with AP; a 
large number of plants habitually used in apiaries could be a source of significant levels of 
the toxins.  
Other alkaloids of interest due to their potential residual effect on animal subproducts are 
the indolizidinics (especially swainsonine) producing lysosomal storage disease and 
piperidine (coniin and gamma-conicein) which in acute form can produce muscular 
paralysis and (chronically) teratogenesis (Panter & James, 1990). These last named alkaloids 
seem to be responsible for coturnism, a human disease which occurs following the 
consumption of migrating wild European quail; it is characterised by weakness, muscular 
pain, paralysis of the legs, vomiting and myoglobinuria. It has been postulated that these 
symptoms occur due to the accumulation of coniin in birds’ tissues following the 
consumption of Conium maculatum (López & Bianchini, 1999).  
6.3.2 Glucosinolates 
Glucosinolates, known as mustard oil glucosides as they confer the characteristic flavour on 
black mustard (Brassica nigra), are secondary metabolites produced by plants belonging to 
the  order Brassicales, mainly in the family Brassicaceae (or Cruciferae). Many plants which are 
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common in the human diet belong to this family (broccoli, Brussels sprouts, cabbage and 
cauliflower) and several genera (Brassica, Crambe, Sinapis and Raphanus) including crops 
used for producing vegetal oils. The plant Camelina sativa (false flax) has recently aroused 
interest due to biofuel production. When the oils are extracted, the glucosinolates remain in 
the seed; the resulting press cake is used in animals diet (EFSA, 2008).  
The glucosinolates become hydrolysed by enzymatic action giving place to isothiocyanates, 
thiocyanates, oxazolidinethiones and nitriles. The thiocyanates interfere with iodine capture 
and the oxazolidinethiones with thyroid (T3 and T4) hormone synthesis, leading to 
hypothyroidism and thyroid gland enlargement. Consequently, metabolism in all tissues, 
including the reproductive organs, may become affected.  
It has been shown that high glucosinolate consumption in lactating cows reduces iodine 
levels and increases thiocyanates in milk, the liver and the kidneys. The residues in milk 
account for around 0.1% of the dose received by animals; the residues in muscles and 
viscera are even lower. Residuality has also been found in eggs after rapeseed has been 
administered to egg-laying birds; these also acquire a disagreeable flavour (EFSA, 2008). 
6.3.3 Ptaquiloside 
Bracken fern (genus Pteridium), considered one of the five most abundant plants in the world, 
contains a norsesquiterpene glucoside called ptaquiloside. It has been proved that ptaquiloside 
may cause tumours in the urinary bladder, mammary glands, intestine and other organs in 
laboratory rodents. It causes degeneration of the retina in sheep and causes urinary bladder 
cancer known as bovine enzootic haematuria in cattle. There is epidemiological evidence 
relating the consumption of bracken fern in humans (Japanese population) suffering from 
esophagic and gastric cancer, possibly caused by ptaquiloside. Around 8.6% of the 
ptaquiloside present in P. aquilinum, consumed by lactating cows, is excreted in milk, thereby 
making contaminated raw milk a risk for human health (Alonso-Amelot et al., 1996).  
6.3.4 Tremetol  
This is a liposoluble compound mixture of terpene, sterols, tremetone, hydroxytremetone 
and dehydrotremetone; the last three are present in a ketonic fraction. It is present in the 
perennial plants white snakeroot (Ageratina altissima, previously called Eupatorium rugosum) 
and rayless goldenrod (Haploppapus heterophyllus). This poisoning reached an epidemic 
proportion during the 18th and 19th centuries in the USA (Indiana, Illinois and Ohio), 
producing high mortality, and its aetiological agent was only discovered in 1910. Cows 
accumulate the toxin in fat and excrete it in milk. The toxin becomes diluted in milk 
reception tanks, making such poisoning not very common in modern milk production 
systems. Tremetol produces acidosis, hyperglycaemia and ketonaemia, as a consequence in 
the Krebs cycle inhibitor. The symptoms of poisoning are anorexia, listlessness, weakness, 
stiffness of muscles, vomiting, constipation and coma. Marked acidosis and ketosis may lead 
to death (Lewis & Elvin-Lewis, 2003).  
7. Conclusions 
Interest in diseases caused by food has mainly been orientated towards the acute 
presentation principally produced by microbiological agents; however, consuming food 
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contaminated by chemical substances could lead to chronic exposure leading to the 
presentation of diseases lacking an apparent cause and being difficult to diagnose. Foods of 
animal origin presuppose the risk of contamination, whether from drugs and growth 
promoters used for optimising livestock production systems, or with biological toxins 
present in food ingested by animals. It is thus necessary to control these substances in foods, 
thereby supposing technological and institutional efforts.  
Sanitary authorities must thus promulgate and ensure compliance with standards and 
guidelines concerning the production of harmless foodstuffs. Achieving such objective 
represents a great challenge for underdeveloped and developing countries due to 
institutional difficulties and the limited availability of equipment and qualified personnel. 
All nations must make it a priority to try to ensure the safe consumption of foodstuffs by 
their populations, exercising strict sanitary control aimed to avoid problems of health in the 
population and preventing the appearance of new problems affecting the development of 
the agro-food industry and global trade in foodstuffs. 
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